Arterial biology for the investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. - Taylor,Aj.; Sullenberger,LE.; Lee,HJ. (Circulation, 2004)